Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in CymaBay Therapeutics Inc (Symbol: CBAY), where a total of 3,388 contracts have traded so far, representing approximately 338,800 underlying shares. That amounts to about 50.5% of CBAY's average daily trading volume over the past month of 670,450 shares. Especially high volume was seen for the $7.50 strike call option expiring January 17, 2020, with 3,058 contracts trading so far today, representing approximately 305,800 underlying shares of CBAY. Below is a chart showing CBAY's trailing twelve month trading history, with the $7.50 strike highlighted in orange:
Nevro Corp (Symbol: NVRO) options are showing a volume of 1,680 contracts thus far today. That number of contracts represents approximately 168,000 underlying shares, working out to a sizeable 50.2% of NVRO's average daily trading volume over the past month, of 334,555 shares. Particularly high volume was seen for the $70 strike call option expiring August 16, 2019, with 513 contracts trading so far today, representing approximately 51,300 underlying shares of NVRO. Below is a chart showing NVRO's trailing twelve month trading history, with the $70 strike highlighted in orange:
And Pioneer Natural Resources Co (Symbol: PXD) options are showing a volume of 8,163 contracts thus far today. That number of contracts represents approximately 816,300 underlying shares, working out to a sizeable 48.9% of PXD's average daily trading volume over the past month, of 1.7 million shares. Especially high volume was seen for the $140 strike call option expiring September 20, 2019, with 1,237 contracts trading so far today, representing approximately 123,700 underlying shares of PXD. Below is a chart showing PXD's trailing twelve month trading history, with the $140 strike highlighted in orange:
For the various different available expirations for CBAY options, NVRO options, or PXD options, visit StockOptionsChannel.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
